SHARx Weighs in on the Future of Affordable Prescription Access

SHARx VP of Sourcing & Pharmacy Relations Otto Graham shares his perspective on prescription affordability and examines growing concerns among patients who depend on lower-cost prescription medications from Canada as new federal import rules threaten to disrupt access. Otto and Sloan discuss the uncertainty these changes create for individuals already struggling with high medication costs and the importance of maintaining affordable prescription options.